These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 11016910

  • 1. Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure.
    Yoshimura M, Mizuno Y, Harada E, Nakayama M, Shimasaki Y, Ito T, Nakamura S, Soejima H, Miyamoto S, Takazoe K, Ogawa H, Kugiyama K, Saito Y, Nakao K, Yasue H.
    Metabolism; 2000 Sep; 49(9):1228-33. PubMed ID: 11016910
    [Abstract] [Full Text] [Related]

  • 2. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
    Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H.
    J Clin Invest; 1991 Apr; 87(4):1402-12. PubMed ID: 1849149
    [Abstract] [Full Text] [Related]

  • 3. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB, O'Brien RJ, Demme B, Davies JE, Ng LL.
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [Abstract] [Full Text] [Related]

  • 4. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K.
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [Abstract] [Full Text] [Related]

  • 5. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].
    Mazurek W, Salomon P.
    Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795
    [Abstract] [Full Text] [Related]

  • 6. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B, Opolski G.
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [Abstract] [Full Text] [Related]

  • 7. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB, Bacevicius E, Bech JN, Solling K, Pedersen HB.
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [Abstract] [Full Text] [Related]

  • 8. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A, Staudt Y, Hummel A, Empen K, Dörr M, Trimpert C, Birkenmeier K, Kühl U, Noutsias M, Russ D, Felix SB.
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [Abstract] [Full Text] [Related]

  • 9. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
    Uetake S, Takahashi M, Tamano K, Honda T, Kobayashi T, Horinaka S.
    J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
    [Abstract] [Full Text] [Related]

  • 10. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.
    Bentzen H, Pedersen RS, Pedersen HB, Nyvad O, Pedersen EB.
    Clin Sci (Lond); 2003 Mar; 104(3):303-12. PubMed ID: 12605591
    [Abstract] [Full Text] [Related]

  • 11. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y, Shimada T, Inoue S, Shimizu H, Ohta Y, Katoh H, Nakamura K, Ishibashi Y.
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [Abstract] [Full Text] [Related]

  • 12. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ, Frampton CM, Yandle TG, Troughton RW, Lainchbury JG, Richards AM.
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [Abstract] [Full Text] [Related]

  • 13. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB, Ørn S, Ng LL, Manhenke C, Shipley L, Aarsland T, Dickstein K.
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [Abstract] [Full Text] [Related]

  • 14. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
    Yamada T, Murakami Y, Okada T, Okamoto M, Shimizu T, Toyama J, Yoshida Y, Tsuboi N, Ito T, Muto M, Kondo T, Inden Y, Hirai M, Murohara T.
    Am J Cardiol; 2006 Jun 15; 97(12):1741-4. PubMed ID: 16765125
    [Abstract] [Full Text] [Related]

  • 15. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
    Davis ME, Richards AM, Nicholls MG, Yandle TG, Frampton CM, Troughton RW.
    Circulation; 2006 Feb 21; 113(7):977-85. PubMed ID: 16476851
    [Abstract] [Full Text] [Related]

  • 16. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K, Onishi K, Dohi K, Tanabe M, Kurita T, Yamanaka T, Ito M, Isaka N, Nobori T, Nakano T.
    Int J Cardiol; 2005 Oct 10; 104(3):332-7. PubMed ID: 16186065
    [Abstract] [Full Text] [Related]

  • 17. [Atrial and B-type natriuretic peptides: from the research lab to clinical practice].
    Boomsma F, van den Meiracker AH.
    Ned Tijdschr Geneeskd; 2003 Apr 19; 147(16):743-8. PubMed ID: 12731463
    [Abstract] [Full Text] [Related]

  • 18. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
    Gill D, Seidler T, Troughton RW, Yandle TG, Frampton CM, Richards M, Lainchbury JG, Nicholls G.
    Clin Sci (Lond); 2004 Feb 19; 106(2):135-9. PubMed ID: 12974669
    [Abstract] [Full Text] [Related]

  • 19. Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.
    Wasywich CA, Webster MW, Richards AM, Stewart RA.
    Am J Cardiol; 2006 Apr 01; 97(7):1068-72. PubMed ID: 16563918
    [Abstract] [Full Text] [Related]

  • 20. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism.
    Kiely DG, Kennedy NS, Pirzada O, Batchelor SA, Struthers AD, Lipworth BJ.
    Respir Med; 2005 Oct 01; 99(10):1286-91. PubMed ID: 16099151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.